Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Novel Prediction Score for Postoperative Acute Renal Failure (ARF) Following Liver Resection (StV 11-2008)
This study has been completed.
Sponsored by: University of Zurich
Information provided by: University of Zurich
ClinicalTrials.gov Identifier: NCT00743132
  Purpose

ARF is a frequent event after hepatic resection and therefore clinically highly relevant.

There is limited evidence on the incidence of postoperative ARF and its clinical relevance in patients undergoing liver resection.

This study will evaluate the incidence of acute renal failure (ARF) after liver resection and its impact on postoperative mortality.


Condition
Acute Renal Failure

MedlinePlus related topics: Kidney Failure
U.S. FDA Resources
Study Type: Observational
Study Design: Cohort, Retrospective
Official Title: Novel Prediction Score for Postoperative Acute Renal Failure (ARF) Following Liver Resection

Further study details as provided by University of Zurich:

Primary Outcome Measures:
  • Predictor score [ Designated as safety issue: Yes ]
  • Incidence of ARF Length of hospital stay [ Designated as safety issue: Yes ]

Biospecimen Retention:   None Retained

Biospecimen Description:

No


Enrollment: 569
Study Start Date: April 2008
Study Completion Date: August 2008
Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)
Groups/Cohorts
1
Postoperative no renal dysfunction
2
Postoperative renal dysfunction

Detailed Description:

ARF is a frequent event after hepatic resection and therefore clinically highly relevant.

There is limited evidence on the incidence of postoperative ARF and its clinical relevance in patients undergoing liver resection.

This study will evaluate the incidence of acute renal failure (ARF) after liver resection and its impact on postoperative mortality.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients with benign and malign liver diseases of the Swiss HPB (Hepato-Pancreato-Biliary) Center undergoing liver resection from 2002 - 2007

Criteria

Inclusion Criteria:

  • Patient age >/= 18 years
  • Benign and malign liver diseases

Exclusion Criteria:

  • Trauma cases
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00743132

Locations
Switzerland
Swiss HPB (Hepato-Pancreato-Biliary) Center of the University Hospital Zurich
Zurich, Switzerland, 8091
Sponsors and Collaborators
University of Zurich
  More Information

Responsible Party: Swiss HPB (Hepato-Pancreato-Biliary) Center, Department of Surgery ( med. pract. Ksenija Slankamenac )
Study ID Numbers: StV 11-2008, StV 11-2008
Study First Received: August 27, 2008
Last Updated: November 19, 2008
ClinicalTrials.gov Identifier: NCT00743132  
Health Authority: Switzerland: Ethikkommission

Keywords provided by University of Zurich:
evaluation
incidence
liver surgery
resection
impact
postoperative
mortality

Study placed in the following topic categories:
Renal Insufficiency
Urologic Diseases
Renal Insufficiency, Acute
Kidney Diseases
Kidney Failure, Acute
Kidney Failure

ClinicalTrials.gov processed this record on January 16, 2009